Core Viewpoint - Hengtong Holdings has experienced fluctuations in stock price and trading volume, with a notable increase in revenue and net profit year-on-year, indicating potential growth in the company's financial performance [1][2]. Group 1: Stock Performance - On January 12, Hengtong's stock price fell by 2.06% to 5.71 CNY per share, with a trading volume of 200 million CNY and a turnover rate of 1.16%, resulting in a total market capitalization of 16.984 billion CNY [1]. - Year-to-date, Hengtong's stock price has increased by 7.13%, with a 9.60% rise over the last five trading days, a 32.48% increase over the last 20 days, and a 27.46% increase over the last 60 days [1]. Group 2: Financial Performance - For the period from January to September 2025, Hengtong achieved operating revenue of 1.262 billion CNY, representing a year-on-year growth of 38.94%, while the net profit attributable to shareholders was 189 million CNY, reflecting a slight increase of 0.68% year-on-year [2]. - The company has distributed a total of 709 million CNY in dividends since its A-share listing, with no dividends paid in the last three years [3]. Group 3: Shareholder Information - As of September 30, 2025, Hengtong had 51,800 shareholders, an increase of 51.38% from the previous period, with an average of 57,388 circulating shares per shareholder, a decrease of 33.94% [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the eighth largest, holding 21.294 million shares as a new shareholder [3].

Group 1 - The core viewpoint of the news is that Hengtong Holdings has shown significant stock performance, with a year-to-date increase of 103.92% and a recent rise of 2.16% in stock price [1] - As of December 25, the stock price reached 5.20 yuan per share, with a total market capitalization of 15.467 billion yuan [1] - The company has experienced a net inflow of main funds amounting to 9.6066 million yuan, with large orders contributing significantly to the trading volume [1] Group 2 - Hengtong Holdings, established on May 11, 1999, primarily engages in the production and sales of biopesticides, veterinary drugs, and feed additives, with a revenue composition of 67.62% from electrolytic copper foil [2] - As of September 30, 2025, the company reported a revenue of 1.262 billion yuan, reflecting a year-on-year growth of 38.94%, and a net profit attributable to shareholders of 189 million yuan, with a slight increase of 0.68% [2] - The company has a total of 51,800 shareholders as of September 30, 2025, which is an increase of 51.38% from the previous period [2] Group 3 - Hengtong Holdings has cumulatively distributed 709 million yuan in dividends since its A-share listing, with no dividends paid in the last three years [3] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the eighth largest shareholder, holding 21.294 million shares as a new investor [3]

Core Viewpoint - Hengtong Holdings has experienced a stock price increase of 68.63% year-to-date, but recent trading shows mixed performance with a slight decline in the last 20 days [1][2] Group 1: Stock Performance - As of November 19, Hengtong's stock price is 4.30 CNY per share, with a market capitalization of 12.79 billion CNY [1] - The stock has seen a trading volume of 69.18 million CNY, with a turnover rate of 0.53% [1] - Year-to-date, the stock has risen by 68.63%, with a recent 5-day increase of 1.18%, a 20-day decline of 5.49%, and a 60-day increase of 35.65% [1] Group 2: Financial Performance - For the period from January to September 2025, Hengtong achieved a revenue of 1.26 billion CNY, representing a year-on-year growth of 38.94% [2] - The net profit attributable to shareholders for the same period was 189 million CNY, showing a slight increase of 0.68% year-on-year [2] Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders has increased by 51.38% to 51,800 [2] - The average number of circulating shares per shareholder is 57,388, which has decreased by 33.94% [2] - Hengtong has distributed a total of 709 million CNY in dividends since its A-share listing, with no dividends paid in the last three years [3]

Core Viewpoint - Hengtong Holdings has experienced significant stock price fluctuations in 2023, with a year-to-date increase of 65.10% but a recent decline of 9.66% over the past five trading days [2] Group 1: Stock Performance - As of October 31, Hengtong's stock price rose by 2.18% to 4.21 CNY per share, with a total market capitalization of 12.52 billion CNY [1] - The stock has seen a trading volume of 64.89 million CNY, with a turnover rate of 0.53% [1] - Year-to-date, Hengtong's stock has been on the龙虎榜 (top trading list) once, with a net buy of 48.06 million CNY on August 29 [2] Group 2: Financial Performance - For the period from January to September 2025, Hengtong reported a revenue of 1.262 billion CNY, reflecting a year-on-year growth of 38.94% [2] - The net profit attributable to shareholders for the same period was 189 million CNY, showing a slight increase of 0.68% year-on-year [2] Group 3: Business Overview - Hengtong Holdings, established on May 11, 1999, primarily operates in the production and sales of biological pesticides, veterinary drugs, and feed additives, with a significant focus on electrolytic copper foil, which constitutes 67.62% of its revenue [2] - The company is classified under the public utility sector, specifically in electricity and heat services, and is involved in various concept sectors including lithium batteries and copper foil [2] Group 4: Shareholder Information - As of September 30, 2025, Hengtong had 51,800 shareholders, an increase of 51.38% from the previous period, with an average of 57,388 circulating shares per shareholder, down by 33.94% [2] - The company has cumulatively distributed 709 million CNY in dividends since its A-share listing, with no dividends paid in the last three years [3]

Core Viewpoint - Hengtong Holdings has shown significant stock performance with a year-to-date increase of 72.55%, despite a recent decline of 4.76% over the past five trading days [1] Financial Performance - For the first half of 2025, Hengtong Holdings achieved a revenue of 818 million yuan, representing a year-on-year growth of 45.80%, and a net profit attributable to shareholders of 127 million yuan, up 8.91% year-on-year [2] Stock Market Activity - As of October 21, Hengtong Holdings' stock price was 4.40 yuan per share, with a market capitalization of 13.087 billion yuan. The stock experienced a trading volume of 63.78 million yuan and a turnover rate of 0.49% [1] - The company has seen a net inflow of main funds amounting to 5.1236 million yuan, with significant buying activity from large orders [1] Shareholder Information - As of June 30, the number of shareholders for Hengtong Holdings was 34,200, an increase of 0.64% from the previous period, with an average of 86,876 circulating shares per shareholder, a decrease of 3.39% [2] Business Overview - Hengtong Holdings, established on May 11, 1999, and listed on November 16, 1999, is primarily engaged in the production and sales of biopesticides, veterinary drugs, feed additives, and related services. The main revenue sources are electrolytic copper foil (67.62%), electricity and steam (16.17%), and veterinary drugs (16.14%) [1][2] Dividend Information - Since its A-share listing, Hengtong Holdings has distributed a total of 709 million yuan in dividends, with no dividends paid in the last three years [3]

Core Viewpoint - Hengtong Holdings has experienced a significant stock price increase of 83.14% year-to-date, despite a recent decline of 2.10% in its stock price on October 16, 2023, indicating volatility in the market [1]. Group 1: Stock Performance - As of October 16, 2023, Hengtong's stock price is reported at 4.67 CNY per share, with a total market capitalization of 13.89 billion CNY [1]. - The stock has seen a trading volume of 1.68 billion CNY, with a turnover rate of 1.20% [1]. - Year-to-date, the stock has increased by 83.14%, with a 1.06% decline over the last five trading days, a 29.36% increase over the last 20 days, and a 58.84% increase over the last 60 days [1]. Group 2: Financial Metrics - For the first half of 2025, Hengtong achieved a revenue of 818 million CNY, representing a year-on-year growth of 45.80%, and a net profit attributable to shareholders of 127 million CNY, reflecting an 8.91% increase [2]. - The company's main revenue sources include electrolytic copper foil (67.62%), electricity and steam (16.17%), and veterinary medicine (16.14%) [2]. Group 3: Shareholder Information - As of June 30, 2023, Hengtong had 34,200 shareholders, an increase of 0.64% from the previous period, with an average of 86,876 circulating shares per shareholder, a decrease of 3.39% [2]. - The company has cumulatively distributed 709 million CNY in dividends since its A-share listing, with no dividends paid in the last three years [3].

Company Overview - Zhejiang Hengtong Holdings Co., Ltd. is located in Deqing County, Huzhou City, Zhejiang Province, and was established on May 11, 1999. The company was listed on November 16, 1999 [2] - The main business involves the production and sales of biopesticides, veterinary drugs, feed additives, and related services such as combined heat and power [2] - The revenue composition includes: 67.62% from electrolytic copper foil, 16.17% from electricity and steam, 16.14% from veterinary drugs, and 0.06% from other businesses [2] Financial Performance - For the first half of 2025, the company achieved operating revenue of 818 million yuan, representing a year-on-year growth of 45.80%. The net profit attributable to the parent company was 127 million yuan, with a year-on-year increase of 8.91% [2] - Since its A-share listing, the company has distributed a total of 709 million yuan in dividends, with no dividends paid in the last three years [3] Stock Performance - On September 12, the stock price increased by 2.19%, reaching 3.73 yuan per share, with a trading volume of 319 million yuan and a turnover rate of 2.93%. The total market capitalization is 11.094 billion yuan [1] - Year-to-date, the stock price has risen by 46.27%, with a 5-day increase of 5.37%, a 20-day increase of 28.18%, and a 60-day increase of 42.37% [1] - The company has appeared on the "Dragon and Tiger List" once this year, with the most recent appearance on August 29, where it recorded a net purchase of 48.0576 million yuan [1]